Skip to content
Open access · CC-BY via OpenAlex

A variant in the 5′UTR of ERBB4 is associated with lifespan in Golden Retrievers

Robert B. Rebhun, Daniel S. York, Flora M. D. De Graaf, Paula Yoon, Kevin Batcher, Madison E. Luker, Stephanie Ryan, Jamie L. Peyton, Michael Sean Kent, Joshua A. Stern, Danika L. Bannasch

GeroScience · 2023 · ▲ 3 citations

Abstract

Genome-wide association studies (GWAS) in long-lived human populations have led to identification of variants associated with Alzheimer's disease and cardiovascular disease, the latter being the most common cause of mortality in people worldwide. In contrast, naturally occurring cancer represents the leading cause of death in pet dogs, and specific breeds like the Golden Retriever (GR) carry up to a 65% cancer-related death rate. We hypothesized that GWAS of long-lived GRs might lead to the identification of genetic variants capable of modifying longevity within this cancer-predisposed breed. A GWAS was performed comparing GR dogs ≥ 14 years to dogs dying prior to age 12 which revealed a significant association to ERBB4, the only member of the epidermal growth factor receptor family capable of serving as both a tumor suppressor gene and an oncogene. No coding variants were identified, however, distinct haplotypes in the 5'UTR were associated with reduced lifespan in two separate populations of GR dogs. When all GR dogs were analyzed together (n = 304), the presence of haplotype 3 was associated with shorter survival (11.8 years vs. 12.8 years, p = 0.024). GRs homozygous for haplotype 3 had the shortest survival, and GRs homozygous for haplotype 1 had the longest survival (11.6 years vs. 13.5 years, p = 0.0008). Sub-analyses revealed that the difference in lifespan for GRs carrying at least 1 copy of haplotype 3 was specific to female dogs (p = 0.009), whereas survival remained significantly different in both male and female GRs homozygous for haplotype 1 or haplotype 3 (p = 0.026 and p = 0.009, respectively). Taken together, these findings implicate a potential role for ERBB4 in GR longevity and provide evidence that within-breed canine lifespan studies could serve as a mechanism to identify favorable or disease-modifying variants important to the axis of aging and cancer.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1007/s11357-023-00968-2
Canonical
link ↗
Fetched
2026-10-24 MST

Cite this

APA
Rebhun, R.B., York, D.S., Graaf, F.M.D.D., Yoon, P., Batcher, K., Luker, M.E., Ryan, S., Peyton, J.L., Kent, M.S., Stern, J.A., &amp; Bannasch, D.L. (2023). A variant in the 5′UTR of ERBB4 is associated with lifespan in Golden Retrievers. <em>GeroScience</em>. https://doi.org/10.1007/s11357-023-00968-2
Vancouver
Rebhun RB, York DS, Graaf FMDD, Yoon P, Batcher K, Luker ME, et al. A variant in the 5′UTR of ERBB4 is associated with lifespan in Golden Retrievers. GeroScience. 2023. doi:10.1007/s11357-023-00968-2.
BibTeX
@article{robert2023Avaria, title = {A variant in the 5′UTR of ERBB4 is associated with lifespan in Golden Retrievers}, author = {Robert B. Rebhun and Daniel S. York and Flora M. D. De Graaf and Paula Yoon and Kevin Batcher and Madison E. Luker and Stephanie Ryan and Jamie L. Peyton and Michael Sean Kent and Joshua A. Stern and Danika L. Bannasch}, journal = {GeroScience}, year = {2023}, doi = {10.1007/s11357-023-00968-2}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings